Eps Summary of Core One Labs Inc.

Core One Labs Inc.'s latest annual eps in 2022 was -0.49 CAD , up 80.93% from previous year.
Core One Labs Inc.'s latest quarterly eps in 2023 Q3 was -0.03 CAD , down -174.23% from previous quarter.
Core One Labs Inc. reported an annual eps of -2.57 CAD in 2021, up 74.98% from previous year.
Core One Labs Inc. reported an annual eps of -10.27 CAD in 2020, up 32.66% from previous year.
Core One Labs Inc. reported a quarterly eps of -0.01 CAD for 2023 Q2, up 96.41% from previous quarter.
Core One Labs Inc. reported a quarterly eps of -0.03 CAD for 2023 Q3, down -174.23% from previous quarter.

Annual Eps Chart of Core One Labs Inc. (2022 - 2011)

Historical Annual Eps of Core One Labs Inc. (2022 - 2011)

Year	Eps	Eps Growth
2022	-0.49 CAD	80.93%
2021	-2.57 CAD	74.98%
2020	-10.27 CAD	32.66%
2019	-15.25 CAD	-44.41%
2018	-10.56 CAD	39.73%
2017	-17.52 CAD	-101.15%
2016	-8.71 CAD	-11.81%
2015	-7.79 CAD	35.41%
2014	-12.06 CAD	14.53%
2013	-14.11 CAD	4.4%
2012	-14.76 CAD	-38.59%
2011	-10.65 CAD	0.0%

Year	Eps	Eps Growth
2023 Q1	-0.27 CAD	-247.49%
2023 Q2	-0.01 CAD	96.41%
2023 Q3	-0.03 CAD	-174.23%
2022 FY	- CAD	80.93%
2022 Q4	-0.08 CAD	-106.1%
2022 Q1	-0.47 CAD	-395.26%
2022 Q2	-0.00 CAD	99.7%
2022 Q3	-0.04 CAD	-2592.86%
2021 FY	- CAD	74.98%
2021 Q1	-1.96 CAD	0.0%
2021 Q2	-0.42 CAD	78.57%
2021 Q3	-0.37 CAD	11.9%
2021 Q4	-0.09 CAD	74.35%
2020 Q2	0.22 CAD	107.97%
2020 Q3	-2.89 CAD	-1413.64%
2020 Q4	- CAD	100.0%
2020 FY	- CAD	32.66%
2020 Q1	-2.76 CAD	0.0%
2019 Q2	-2.61 CAD	-209.66%
2019 FY	- CAD	-44.41%
2019 Q4	- CAD	100.0%
2019 Q1	2.38 CAD	169.39%
2019 Q3	-4.14 CAD	-58.62%
2018 Q4	-3.43 CAD	-9.58%
2018 FY	- CAD	39.73%
2018 Q2	-2.50 CAD	-32.98%
2018 Q1	-1.88 CAD	0.0%
2018 Q3	-3.13 CAD	-25.2%
2017 Q2	-1.43 CAD	-16.26%
2017 Q1	-1.23 CAD	0.0%
2017 Q4	- CAD	100.0%
2017 FY	- CAD	-101.15%
2017 Q3	-4.87 CAD	-240.56%
2016 Q2	-1.28 CAD	-2.4%
2016 Q3	-2.19 CAD	-71.09%
2016 Q4	- CAD	100.0%
2016 FY	- CAD	-11.81%
2016 Q1	-1.25 CAD	0.0%
2015 Q2	-2.90 CAD	-107.14%
2015 Q4	- CAD	100.0%
2015 Q3	-1.90 CAD	34.48%
2015 FY	- CAD	35.41%
2015 Q1	-1.40 CAD	76.39%
2014 Q3	-3.34 CAD	-162.99%
2014 Q1	-1.81 CAD	22.32%
2014 Q2	-1.27 CAD	29.83%
2014 FY	- CAD	14.53%
2014 Q4	-5.93 CAD	-77.54%
2013 Q2	-6.78 CAD	-190.99%
2013 FY	- CAD	4.4%
2013 Q1	-2.33 CAD	2.92%
2013 Q3	-2.69 CAD	60.32%
2013 Q4	-2.33 CAD	13.38%
2012 Q3	-2.39 CAD	12.45%
2012 Q1	-7.39 CAD	0.0%
2012 FY	- CAD	-38.59%
2012 Q2	-2.73 CAD	63.06%
2012 Q4	-2.40 CAD	-0.42%
2011 FY	- CAD	0.0%
2011 Q1	-2.14 CAD	0.0%
2011 Q2	-2.01 CAD	6.07%
2011 Q3	-7.47 CAD	-271.64%
2011 Q4	- CAD	100.0%
2010 Q3	-0.00 CAD	0.0%

Peer Eps Comparison of Core One Labs Inc.

Name	Eps	Eps Difference
Nuo Therapeutics, Inc.	-0.08 USD	-549.867%
CNBX Pharmaceuticals Inc.	-0.42 USD	-16.667%
Mosaic ImmunoEngineering Inc.	-0.33 USD	-48.485%
Evofem Biosciences, Inc.	10.35 USD	104.734%
GB Sciences, Inc.	-0.00 USD	-11851.22%
Inhibitor Therapeutics, Inc.	-0.02 USD	-2350.0%
NanoSphere Health Sciences Inc.	-0.02 USD	-2107.207%
Skye Bioscience, Inc.	-5.37 USD	90.875%
Zenith Capital Corp.	-0.07 USD	-601.001%
Agentix Corp.	-0.04 USD	-1300.0%
Arch Therapeutics, Inc.	-2.27 USD	78.414%
Biomind Labs Inc.	-0.02 USD	-2924.691%
ContraFect Corporation	-124.97 USD	99.608%
CSL Limited	2.73 USD	117.949%
CytoDyn Inc.	-0.05 USD	-826.276%
GlobeStar Therapeutics Corporation	-0.00 USD	-20316.667%
Neon Bloom, Inc.	-0.00 USD	-32566.667%
Northwest Biotherapeutics, Inc.	-0.06 USD	-752.174%
ProtoKinetix, Incorporated	-0.01 USD	-4800.0%
Propanc Biopharma, Inc.	-0.02 USD	-1967.511%
Regen BioPharma, Inc.	0.26 USD	288.462%
Santhera Pharmaceuticals Holding AG	5.95 USD	108.235%
SQZ Biotechnologies Company	-2.76 USD	82.246%
Therapeutic Solutions International, Inc.	-0.00 USD	-69900.0%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	99.035%
Intellipharmaceutics International Inc.	-0.09 USD	-460.641%
Mesoblast Limited	-0.09 USD	-449.944%
Marizyme, Inc.	-1.44 USD	65.972%
Genus plc	0.12 USD	508.333%
Pharming Group N.V.	-0.02 USD	-2943.478%
Nymox Pharmaceutical Corporation	-0.10 USD	-407.772%
RegeneRx Biopharmaceuticals, Inc.	-0.01 USD	-3983.333%
IMV Inc.	-4.37 USD	88.787%
AXIM Biotechnologies, Inc.	-0.04 USD	-1284.181%
MultiCell Technologies, Inc.	-0.00 USD	-489900.0%
ONE Bio Corp.	1.43 USD	134.266%
RVL Pharmaceuticals plc	-0.58 USD	15.517%
Arno Therapeutics, Inc.	- USD	Infinity%
Emmaus Life Sciences, Inc.	-0.07 USD	-597.013%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	-6521.622%
Oncotelic Therapeutics, Inc.	-0.02 USD	-2362.312%
THC Farmaceuticals, Inc.	-0.00 USD	-61150.0%
Acro Biomedical Co., Ltd.	-0.26 USD	-88.462%
Alpha Cognition Inc.	-0.15 USD	-226.667%
Enzolytics Inc.	-0.00 USD	-69900.0%
MetaStat, Inc.	- USD	Infinity%
argenx SE	-5.16 USD	90.504%
Enzon Pharmaceuticals, Inc.	0.00 USD	37792.308%
Endonovo Therapeutics, Inc.	0.03 USD	2052.191%
Genscript Biotech Corporation	-0.05 USD	-979.295%
Nanobac Pharmaceuticals, Incorporated	- USD	Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	-851.456%
Sigyn Therapeutics, Inc.	-3.77 USD	87.003%
WPD Pharmaceuticals Inc.	-0.00 USD	-97900.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	-436.692%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	78.97%
PsyBio Therapeutics Corp.	-0.04 USD	-1066.667%
Adynxx, Inc.	- USD	Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
Accustem Sciences Inc.	-0.34 USD	-44.118%
Helix BioMedix, Inc.	-4.70 USD	89.574%
EV Biologics, Inc.	-0.12 USD	-308.333%
Q BioMed Inc.	-0.08 USD	-527.401%
Capstone Therapeutics Corp.	-36.39 USD	98.653%
American Oriental Bioengineering, Inc.	-781.24 USD	99.937%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
BioStem Technologies, Inc.	-0.62 USD	20.968%
Curative Biotechnology, Inc.	-0.01 USD	-5468.182%
HST Global, Inc.	-0.03 USD	-1656.272%
Burzynski Research Institute, Inc.	-0.01 USD	-4703.922%
Wesana Health Holdings Inc.	-0.05 USD	-878.044%
Halberd Corporation	-0.00 USD	-489900.0%
Resverlogix Corp.	-0.01 USD	-3350.704%
Cell Source, Inc.	-0.17 USD	-188.235%
RespireRx Pharmaceuticals Inc.	-0.04 USD	-1272.549%
GeneThera, Inc.	- USD	Infinity%
AVAX Technologies, Inc.	-0.05 USD	-809.091%
Ember Therapeutics, Inc.	-0.01 USD	-7677.778%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
NovAccess Global Inc.	-0.23 USD	-113.043%
Kadimastem Ltd	-0.78 USD	37.179%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
Rasna Therapeutics, Inc.	-0.01 USD	-4800.0%
Oncology Pharma Inc.	- USD	Infinity%
Reve Technologies, Inc.	-0.01 USD	-4017.647%
LadRx Corporation	0.68 USD	172.059%
Regen BioPharma, Inc.	0.29 USD	268.966%
Affymax, Inc.	-0.39 USD	-25.641%
Itoco Inc.	-0.01 USD	-6347.368%
Pathfinder Cell Therapy, Inc.	-0.00 USD	-19500.0%
Mobile Lads Corp.	-0.01 USD	-8650.0%
International Stem Cell Corporation	-0.02 USD	-2887.805%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
Bioxytran, Inc.	-0.03 USD	-1436.05%
NDT Pharmaceuticals Inc.	-0.00 USD	-97900.0%
Qrons Inc.	-0.06 USD	-740.48%
Alseres Pharmaceuticals, Inc.	-153.67 USD	99.681%
SYBLEU INC	-0.02 USD	-2700.0%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
Nascent Biotech, Inc.	-0.01 USD	-3556.716%
Rebus Holdings, Inc.	-0.03 USD	-1426.48%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	-3350.704%
GlobeImmune, Inc.	- USD	Infinity%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	- USD	Infinity%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	-0.00 USD	-489900.0%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	-7.99 USD	93.867%
Adhera Therapeutics, Inc.	-1.18 USD	58.475%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	-0.03 USD	-1341.176%
Innovation Pharmaceuticals Inc.	-0.01 USD	-7677.778%
Neutra Corp.	-0.00 USD	-489900.0%
Windtree Therapeutics, Inc.	-94.23 USD	99.48%
PureTech Health plc	-2.38 USD	79.412%
Coeptis Therapeutics, Inc.	-0.83 USD	40.964%
IXICO plc	-0.02 USD	-1908.197%
IntelGenx Technologies Corp.	-0.06 USD	-762.676%
Gelesis Holdings, Inc.	-1.35 USD	63.704%
CSL Limited	5.47 USD	108.958%
Cellectis S.A.	-1.77 USD	72.316%

Global Stocks Search

Core One Labs Inc. (CLABF)

Eps Summary of Core One Labs Inc.

Annual Eps Chart of Core One Labs Inc. (2022 - 2011)

Historical Annual Eps of Core One Labs Inc. (2022 - 2011)

Peer Eps Comparison of Core One Labs Inc.